Suraksha Diagnostic Ltd
NSE: SURAKSHA | BSE: 544293
₹270.80
₹1.15
(0.43%)
As on 10-Jun-2026IST
Market cap
₹1,405 Cr
Revenue (TTM)
₹310 Cr
P/E Ratio
43.6
P/B Ratio
5.7
Div. Yield
0.2 %
Quality Score
9/10
Growth Score
3/10
Valuation Score
5/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹32 Cr
-
ROE
15.9 %
-
ROCE
24.9 %
-
Industry P/E
57.21
-
EV/EBITDA
14
-
Debt to Equity
0
-
Book Value
₹47
-
EPS
₹6.2
-
Face value
2
-
Shares outstanding
52,080,758
10 Years Aggregate
CFO
₹319.43 Cr
EBITDA
₹408.63 Cr
Net Profit
₹140.99 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Suraksha Diagnostic
| 0.4 | -7.3 | 3.9 | -19.2 | -- | -- | -- |
|
BSE Healthcare
| 8.2 | 1.0 | 8.3 | 8.0 | 24.8 | 13.5 | 12.1 |
|
Company
|
2025
|
|---|---|
|
Suraksha Diagnostic
| -29.1 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Suraksha Diagnostic
|
270.8 | 1,404.9 | 310.4 | 31.4 | 17.4 | 13.5 | 43.6 | 5.7 |
| 228.7 | 559.1 | 230.1 | 23.5 | -- | 28.7 | 20.7 | 3.3 | |
| 1,568.7 | 26,329.2 | 2,762.9 | 509.8 | 22.5 | 21.5 | 52.2 | 10.5 | |
| 763.2 | 30,574.6 | 3,904.6 | 239.4 | 13.3 | 11.1 | 126.7 | 13.6 | |
| 534.8 | 1,736.6 | 772.8 | 101.5 | 15.7 | 10.7 | 17.1 | 1.8 | |
| 524.5 | 10,871.5 | 1,645.9 | 191.2 | 16.2 | 13.3 | 57.2 | 7.2 | |
| 723.2 | 7,216.0 | 755.8 | 67.1 | -- | 13.8 | 93.9 | 6.5 | |
| 286.5 | 912.6 | 1,319.3 | -1.5 | -4.5 | 0.3 | 776.1 | 1.4 | |
| 532.8 | 8,475.6 | 829.0 | 162.9 | 24.5 | 29 | 51.9 | 14.6 | |
| 1,269.7 | 13,022.1 | 814.2 | 173.0 | 30.1 | 19 | 75.3 | 13.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Suraksha Diagnostic
--
-
Incorporated
2005
-
Chairman
Somnath Chatterjee
-
Managing Director
--
-
Headquarters
Kolkata, West Bengal
-
Website
Looking for more details about Suraksha Diagnostic Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
21-May-2026No News & Announcements are available.
FAQs for Suraksha Diagnostic
What is the current share price of Suraksha Diagnostic Ltd Today?
The share price of Suraksha Diagnostic Ltd is ₹270.80 (NSE) and ₹269.75 (BSE) as of 10-Jun-2026 IST. Suraksha Diagnostic Ltd has given a return of -19.25% in the last 1 years.
What is the current PB & PE ratio of Suraksha Diagnostic Ltd?
The P/E ratio of Suraksha Diagnostic Ltd is 43.65 times as on 10-Jun-2026, a 24 discount to its peers’ median range of 57.21 times.
The P/B ratio of Suraksha Diagnostic Ltd is 5.74 times as on 10-Jun-2026, a 45 discount to its peers’ median range of 10.50 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
42.19
|
6.36
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Suraksha Diagnostic Ltd?
The 52-week high and low of Suraksha Diagnostic Ltd are Rs 352.50 and Rs 224.10 as of 11-Jun-2026.
What is the market cap of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has a market capitalisation of ₹ 1,405 Cr as on 10-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Suraksha Diagnostic Ltd?
Before investing in Suraksha Diagnostic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.